Pharmaceutical services for Alzheimer's disease medication therapy management:a case report
10.12173/j.issn.2097-4922.202407159
- VernacularTitle:1例阿尔茨海默病药物治疗管理门诊病例的药学服务
- Author:
Peng XU
1
;
Bowen YI
;
Yu LIU
Author Information
1. 中国中医科学院西苑医院药学部,北京 100091
- Keywords:
Alzheimer's disease;
Sequential therapy;
Medication therapy management;
Pharmaceutical services;
Integration of traditional and western medicine;
Medication related problems
- From:
China Pharmacist
2024;28(10):357-364
- CountryChina
- Language:Chinese
-
Abstract:
At present,pharmaceutical services for Alzheimer's disease (AD) patients are mostly based on the western medication therapy management (MTM) model,which includes conducting drug treatment evaluations for patients,identifying drug treatment issues,proposing drug treatment recommendations,restructuring drug treatment checklists,follow-up visiting and recording,etc.However,in recent years,more and more domestic clinical practices have proven that individualized treatment with dialectical treatment of traditional Chinese medicine can effectively prevent and delay the occurrence and development of AD,while the MTM pharmaceutical service model has some limitations when facing such AD patients.Therefore,it is necessary to explore a new pharmaceutical service model with Chinese medicine characteristics for AD MTM,so as to provide pharmaceutical services for patients receiving individualized treatment of AD through the combination of traditional Chinese and Western medicine.Combining the traditional Chinese medicine sequential therapy of AD with the MTM concept,MTM was conducted on a typical outpatient AD patient,which effectively solved the medication related problems of the patient and ensured the medication safety and efficacy.
